RE:RE:Institutional investor I agree, on the dates.
the trouble with in line ," data," one must read the dates of the data posting & reporting.
which both can be different from the actual date of transaction.
regarding do they Anison still own the shares?
most likely...
how can I draw that conclusion?
since the date of purchase, that many shares has not traded ( on the TSX ), cumulatively since the deal.
volume has been dismal.
also, their motivation is to make $$. Selling at a loss ( since the deal), is not helpful for that.
I do agree 100%, Onc management needs a paradigm shift.
Matt should step aside as president. Stay on as clinical advisor & chairman.
Move Andrew up to " make ONC business focused".
Dr. Coffey has moved the ball to the Finnish line. Multiple trials & many with phase 3 ready results.
Time to bring in the business team.
I do see a deal by end of this year. Aka next few weeks.
way too many " events" have happened last 3 weeks, to be ignored.